EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Home-Based Buddhist Walking Meditation Mitigates Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial

Saowalak Siripanya, Napa Parinyanitikul, Hirofumi Tanaka, Daroonwan Suksom iD

Journal of Integrative and Complementary Medicine · 01.09.2023 · 29 (9) · 562-573

DOI: 10.1089/jicm.2022.0778 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Integrative and Complementary Medicine, erschienen am 01.09.2023. Verfasst von Saowalak Siripanya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Area of Exercise Physiology, Faculty of Sports Science, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Breast Neoplasms, Meditation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate the effect of walking meditation on vascular function, aerobic fitness, and quality of life in breast cancer patients receiving anthracycline chemotherapy and compare with the nonexercising control group.

Methods

Patients aged 40-60 years with newly diagnosed, histologically confirmed resected stage I-II breast cancer were studied in a parallel randomized controlled trial. The participants were randomly assigned to either the nonexercising control group (n = 15) or the Buddhist walking meditation group (n = 15). All participants received four cycles of anthracycline chemotherapy every 3 weeks starting at 2 weeks before the start of the exercise intervention. The walking meditation group performed home-based mindfulness walking exercises at a moderate exercise intensity for 30 min/session, 3 times/week for 12 weeks. The primary outcome measures were vascular reactivity (flow-mediated dilation [FMD]) and arterial stiffness (brachial-ankle pulse wave velocity [baPWV]).

Results

Eleven participants from each group completed the entire study. Analysis of variance with repeated measures indicated that FMD and peak oxygen consumption (VO2peak) decreased in both groups after the initiation of anthracycline chemotherapy (all p < 0.05). After the exercise intervention, FMD, VO2peak, peak stroke volume, and peak cardiac output remained lower in the controls, but improved in the walking meditation group (all p < 0.05). baPWV increased in the control group, while no such change was observed in the walking meditation group. There were no significant changes in blood cortisol, malondialdehyde, and interleukin-6 concentrations in both groups. Overall quality of life decreased after 2 weeks of anthracycline chemotherapy in both groups (all p < 0.05). However, the walking meditation group improved many of these symptoms significantly (all p < 0.05), while no such changes were observed in the control group.

Conclusions

Buddhist walking meditation exercise was effective in mitigating cardiotoxicity of anthracycline chemotherapy on vascular function, aerobic fitness, and quality of life in breast cancer patients. Clinical trial registration number: NCT02676531.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMeditationHumansFemaleCardiotoxicityQuality of LifeAnthracyclinesAnkle Brachial IndexPulse Wave AnalysisWalkingAntibiotics, Antineoplastic

Stichwörter der Autor:innen

adjuvant chemotherapyarterial stiffnesscardio-oncologyendothelial functionmindfulness exercise

Substanzen

AnthracyclinesAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Area of Exercise Physiology, Faculty of Sports Science, Chulalongkorn University, Bangkok, Thailand.
  • Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Department of Kinesiology and Health Education, The University of Texas at Austin, Austin, TX, USA.
  • Exercise Physiology in Special Population Research Unit, Chulalongkorn University, Bangkok, Thailand.

ORCID-Profile: Daroonwan Suksom

Zitieren

APA

Siripanya, S., Parinyanitikul, N., Tanaka, H., & Suksom, D. (2023). Home-Based Buddhist Walking Meditation Mitigates Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial. Journal of Integrative and Complementary Medicine, 29(9), 562-573. https://doi.org/10.1089/jicm.2022.0778

Vancouver

Siripanya S, Parinyanitikul N, Tanaka H, Suksom D. Home-Based Buddhist Walking Meditation Mitigates Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial. Journal of Integrative and Complementary Medicine. 2023;29(9):562-573. doi:10.1089/jicm.2022.0778

BibTeX
@article{Siripanya2023,
  author = {Siripanya, Saowalak and Parinyanitikul, Napa and Tanaka, Hirofumi and Suksom, Daroonwan},
  title = {Home-Based Buddhist Walking Meditation Mitigates Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial},
  journal = {Journal of Integrative and Complementary Medicine},
  year = {2023},
  volume = {29},
  number = {9},
  pages = {562--573},
  doi = {10.1089/jicm.2022.0778}
}
Kostenlos starten →